Clinical Trials
7 trialsNCT01096368 2026-04-30
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma
Children's Oncology Group
Phase 3 Completed
NCT07543887 2026-04-22
EECRTKI
University of Pisa
Completed
NCT04442048 2025-12-30
COV-IMMUNO
Canadian Cancer Trials Group
Phase 3 Completed
NCT02882282 2025-10-23
Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT05323747 2025-09-16
BP-008
BioProtect
Completed
NCT05354427 2025-09-16
CLP-10095
BioProtect
Completed
NCT06702436 2025-09-16
CAN-NSTEMI
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Completed